NDC 63833-891

RiaSTAP

Fibrinogen Human

RiaSTAP is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Csl Behring Gmbh. The primary component is Fibrinogen Human.

• Product ID: 63833-891_129234e9-6d7e-4fa8-81a6-fb354c18f254
• NDC: 63833-891
• Product Type: Plasma Derivative
• Proprietary Name: RiaSTAP
• Generic Name: Fibrinogen Human
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2009-01-16
• Marketing Category: BLA / BLA
• Application Number: BLA125317
• Labeler Name: CSL Behring GmbH
• Substance Name: FIBRINOGEN HUMAN
• Active Ingredient Strength: 1300 mg/50mL
• Pharm Classes: Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 63833-891-51

1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51) > 50 mL in 1 VIAL, SINGLE-USE (63833-891-90)

• Marketing Start Date: 2009-01-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63833-891-51 [63833089151]

RIASTAP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA125317
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2009-01-16

NDC 63833-891-90 [63833089190]

RIASTAP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA125317
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2015-10-15

Drug Details

Active Ingredients

Ingredient	Strength
FIBRINOGEN HUMAN	1300 mg/50mL

Pharmacological Class

• Human Blood Coagulation Factor [EPC]
• Increased Coagulation Activity [PE]
• Blood Coagulation Factors [CS]